Real-life use of Rivaroxaban in the Netherlands: data from the Xarelto for Prevention of Stroke in Patients with Atrial Fibrillation (XANTUS) registry

BACKGROUND: The Xarelto for Prevention of Stroke in Patients with Atrial Fibrillation (XANTUS) registry investigated the safety and efficacy of the factor Xa inhibitor rivaroxaban. We studied the Dutch XANTUS cohort to a ssess drug safety and prescription patterns in the Netherlands. METHODS: The XA...

Descripción completa

Detalles Bibliográficos
Autores principales: Pisters, R., van Vugt, S. P. G., Brouwer, M. A., Elvan, A., ten Holt, W. L., Zwart, P. A. G., Kirchhof, P., Crijns, H. J. G. M., Hemels, M. E. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bohn Stafleu van Loghum 2017
Materias:
Original Article - E‑Learning
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5612862/
https://www.ncbi.nlm.nih.gov/pubmed/28674871
http://dx.doi.org/10.1007/s12471-017-1009-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5612862/
https://www.ncbi.nlm.nih.gov/pubmed/28674871
http://dx.doi.org/10.1007/s12471-017-1009-9

Ejemplares similares